CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis).
Saved in:
| Title: | CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis). |
|---|---|
| Authors: | Magnus, Björkholm1 magnus.bjorkholm@karolinska.se, Tomas, Andersson2,3, Anders, Ahlbom2,3, Eva, Ösby1 |
| Source: | European Journal of Haematology. Jun2008, Vol. 80 Issue 6, p477-482. 6p. 1 Chart, 2 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
